Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 4 of 4 for:    KHK4083

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03703102
Recruitment Status : Completed
First Posted : October 11, 2018
Last Update Posted : February 5, 2021
Kyowa Kirin Co., Ltd.
Information provided by (Responsible Party):
Kyowa Kirin, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 6, 2020
Actual Study Completion Date : November 12, 2020
Certification/Extension First Submitted : February 2, 2021